Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes
- R. Heine, L. V. Van Gaal, D. Johns, M. Mihm, M. Widel, R. Brodows
- Medicine
- Annals of Internal Medicine
- 18 October 2005
Context Are both exenatide and insulin glargine reasonable additions for patients with type 2 diabetes that is suboptimally controlled despite metformin and sulfonylurea therapy? Contribution This… Expand
Expression of a Mutant Form of the Ferritin Light Chain Gene Induces Neurodegeneration and Iron Overload in Transgenic Mice
- R. Vidal, L. Miravalle, +7 authors B. Ghetti
- Biology, Medicine
- The Journal of Neuroscience
- 2 January 2008
Increased iron levels and iron-mediated oxidative stress play an important role in the pathogenesis of many neurodegenerative diseases. The finding that mutations in the ferritin light polypeptide… Expand
Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month,…
- V. Mattoo, D. Eckland, +7 authors M. Tan
- Medicine
- Clinical therapeutics
- 1 May 2005
BACKGROUND
Type 2 diabetes mellitus (DM) is a progressive disease. Initial therapy begins with dietary and lifestyle modifications. However, as the disease progresses, glycemic control becomes more… Expand
Comparison of effect of pioglitazone with metformin or sulfonylurea (monotherapy and combination therapy) on postload glycemia and composite insulin sensitivity index during an oral glucose tolerance…
- A. Ceriello, D. Johns, M. Widel, D. Eckland, K. Gilmore, M. Tan
- Medicine
- Diabetes care
- 1 February 2005
OBJECTIVE
Pioglitazone, metformin, and gliclazide lower HbA(1c) and fasting plasma glucose in patients with type 2 diabetes. We compared the effects of these three drugs, used as monotherapy and in… Expand
Pioglitazone elicits long-term improvements in insulin sensitivity in patients with type 2 diabetes: comparisons with gliclazide-based regimens
- B. Charbonnel, M. Roden, +5 authors M. Tan
- Medicine
- Diabetologia
- 1 March 2005
Aims/hypothesisRecent studies have demonstrated that pioglitazone (PIO) has beneficial effects on insulin sensitivity compared with placebo in patients with type 2 diabetes. The effects of PIO and… Expand
Pioglitazone as monotherapy or in combination with sulfonylurea or metformin enhances insulin sensitivity (HOMA-S or QUICKI) in patients with type 2 diabetes
- M. Tan, N. Glazer, D. Johns, M. Widel, K. Gilmore
- Medicine
- Current medical research and opinion
- 19 March 2004
Background: Miyazaki etal, demonstrated using the hyperinsulinemic, euglycemic clamp that pioglitazone (PIO) enhanced insulin sensitivity in patients (n = 23) with type 2 diabetes (T2D). Although… Expand
Long‐term effects of pioglitazone and metformin on insulin sensitivity in patients with Type 2 diabetes mellitus
- M. Roden, M. Laakso, +5 authors M. Tan
- Medicine
- Diabetic medicine : a journal of the British…
- 1 August 2005
Aim Despite their comparable glycaemic effects in patients with Type 2 diabetes mellitus (T2DM), pioglitazone and metformin may have different effects on insulin sensitivity because they have… Expand
Erratum: Comparison of effect of pioglitazone with metformin or sulfonylurea (monotherapy and combination therapy) on postload glycemia and composite insulin sensitivity index during an oral glucose…
- A. Ceriello, D. Johns, M. Widel, D. Eckland, K. Gilmore, M. Tan
- Medicine
- 1 May 2005
The use of checksums to ensure data integrity in the healthcare industry
- Carey G. Smoak, M. Widel, S. Trương
- Computer Science
- 1 December 2012
TLDR
Adding New Rows in the ADaM Basic Data Structure: When and How
- M. Widel, Sandra Minjoe, Adam Basics
- Computer Science
- 2013
TLDR
- 1
- PDF